J. Blackwell

Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particles.

C. A. Derdeyn, E. Hunter, D. Curiel, 2001, Human gene therapy.

Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid.

C. Richter, D. Curiel, H. Li, 2000, Human gene therapy.

Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells

D. Curiel, J. Thomas, I. Dmitriev, 2002, Gene Therapy.

Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors

P. Bosma, D. Curiel, P. Reynolds, 2001, Gene Therapy.

A three-dimensional assay for measurement of viral-induced oncolysis

R. Desmond, A. Hemminki, A. Kanerva, 2007, Cancer Gene Therapy.

Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.

K. Kasono, D. Curiel, I. Dmitriev, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma.

C. Miller, D. Curiel, P. Reynolds, 1999, Archives of otolaryngology--head & neck surgery.